Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brain receptors and zopiclone.

J C Blanchard, A Boireau, L Julou

    Pharmacology
    |January 1, 1983
    PubMed
    Summary

    Zopiclone (ZPC) exhibits high affinity for benzodiazepine (BZD) receptors in rat brains, distinct from other neurotransmitter receptors. While similar to BZD, ZPC may bind to unique sites, differentiating its mechanism from traditional benzodiazepines.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Study of the pharmacological properties of 2-diethyl-aminoethyl phenothiazine-10-dithiocarboxylate (R.P. 7360)].

    Comptes rendus des seances de la Societe de biologie et de ses filiales·2014
    Same author

    Creation and piloting of a new hospital capacity assessment tool in a major urban area.

    Public health·2009
    Same author

    RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis.

    The Journal of pharmacology and experimental therapeutics·2001
    Same author

    Synthesis of anticonvulsive AMPA antagonists: 4-oxo-10-substituted-imidaz.

    Bioorganic & medicinal chemistry letters·2001
    Same author

    Bioisosteres of 9-carboxymethyl-4-oxo-imidazo[1,2-a]indeno-[1,2-e]pyrazin-2-carboxylic acid derivatives. Progress towards selective, potent in vivo AMPA antagonists with longer durations of action.

    Bioorganic & medicinal chemistry letters·2001
    Same author

    Synthesis and potent anticonvulsant activities of 4-oxo-imidazo[1,2-a]inden.

    Bioorganic & medicinal chemistry letters·2001

    Area of Science:

    • Neuropharmacology
    • Receptor Binding Assays

    Background:

    • Zopiclone (ZPC) shares hypnotic activity with benzodiazepines (BZD) but is chemically distinct.
    • Understanding ZPC's interaction with brain receptors is crucial for elucidating its pharmacological profile.

    Purpose of the Study:

    • To investigate the binding affinity and specificity of Zopiclone (ZPC) to rat brain receptors, particularly benzodiazepine (BZD) receptors.
    • To compare the binding characteristics of ZPC with those of known BZD.

    Main Methods:

    • Radioligand binding assays using [3H]-flunitrazepam and synthesized [3H]-Zopiclone (ZPC) in rat brain homogenates.
    • Determination of inhibition constants (Ki) and dissociation constants (KD) for ZPC binding.
    • Assessment of the modulating effects of gamma-aminobutyric acid and barbiturates on ZPC binding.

    Main Results:

    • Zopiclone (ZPC) demonstrated high affinity for BZD receptors in the cerebral cortex (Ki=24 nM), cerebellum (Ki=31 nM), and hippocampus (Ki=36 nM).
    • ZPC selectively bound to brain BZD receptors, showing no affinity for GABA, dopamine, serotonin, or noradrenergic receptors.
    • ZPC did not bind to peripheral renal BZD-binding sites, unlike some BZD.
    • Equilibrium binding studies confirmed ZPC's high affinity (KD=13±4 nM in hippocampus).
    • Modulation studies revealed differences in ZPC binding compared to BZD, suggesting distinct binding sites.

    Conclusions:

    • Zopiclone (ZPC) binds with high affinity to rat brain benzodiazepine (BZD) receptors.
    • ZPC exhibits selectivity for brain BZD receptors and does not interact with other major neurotransmitter receptors or peripheral BZD sites.
    • Observed differences in modulation suggest ZPC may bind to a subtype of BZD receptor or a related, distinct site in the brain.

    Related Experiment Videos